Catch two transits of Io, spot sparkling star clusters, and view Mars at aphelion while the April Full Moon lights the sky ...

Sky This Week is brought to you in part by Celestron. Friday, April 4This evening, the roughly half-illuminated face of the ...

Former teammate Pierre Gasly, who knows Tsunoda well from their time together at Alpha Tauri, has expressed confidence in Tsunoda ... While Gasly acknowledges that success at Red Bull won’t come easy, ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

Superradiant phase transition seenUntil now, the phenomenon was debated as it defies the “no-go theorem” in light-based ...

A phase 3 trial of Immunovant’s FcRn inhibitor batoclimab has hit its primary endpoint. But, having made a second-generation molecule its lead candidate last year, the biotech isn’t currently ...

Even in the case of uncomplicated infections, the body prepares itself early on for the possibility of a more severe course. A research team has now uncovered this mechanism. The scientists showed ...

“One of the reasons beginners don’t perform well is because they end up getting hurt. They’re not in the base or build phase for long enough, and they don’t produce that durable body ...

Even in the case of uncomplicated infections, the body prepares itself early on for the possibility of a more severe course.

Shares of GRI Bio Inc. (NASDAQ:GRI) were trading at $6.28, up $3.08, or 96%, after the firm reported interim safety results from the ongoing phase IIa study testing GRI-0621 for idiopathic pulmonary ...